Charles river

criver.com · Wilmington Manor, United States of America

Charles River Laboratories is a global contract research organization that provides preclinical and clinical laboratory services, research models, and related support to pharmaceutical, biotechnology, and medical device companies, as well as academic and government institutions. The company helps clients discover, develop, and safely manufacture new drugs and therapies by offering in vivo and in vitro testing, safety assessment, biologics testing, and manufacturing support services. It generates revenue through fee-for-service research, laboratory services, and the sale of research models and related products.

  • IT Consulting & Implementation
Revenue
$4.2B
Employees
21,000
Founded
1947
Headquarters
Wilmington Manor, United States of America

What 38 Arbolus experts think of Charles river

NPS scores are predominantly positive with a concentration in the 8–10 range, but a minority of detractors brought the mean down. Renewal intent is mixed—several large accounts are unsure or plan not to renew, reflecting concerns around evolving regulatory alternatives and budget reevaluations. Most users are in the mature implementation stage (>12 months), indicating deep product adoption and high workflow integration. Experts repeatedly cite Charles River’s strong scientific staff, regulatory compliance, and lab infrastructure as key assets, but also acknowledge ongoing market shifts towards alternatives like NAMs.Overall Customer Sentiment: Positive

Who reviewed Charles river

Total customers 38 35 current · 3 former
Reviews growth +13 in six months
Seniority of respondents
  • C-Suite 68% (26)
  • Director 24% (9)
  • Manager 8% (3)
Data Leader C-Suite NPS 9 Will renew
Other Manager Director NPS 7 Undecided
Strategy Leader C-Suite NPS 8 Will renew

Employer names and spend open in the full report, along with the other 35 customers.

Everything 38 customers told us about Charles river.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Open the full report

Sentiment

26 Net Promoter Score, from 38 scored reviews
  • Promoters 16
  • Passives 16
  • Detractors 6

Cumulative NPS by month

+0 over 6 months
  • Mar 8
  • Jun 8
  • Jul 8
  • Aug 8
  • Sep 8
  • Oct 8

Net Promoter Score across 4 reviews, accumulated up to each month. Category median 34 across 4 companies.

Praised

  • Regulatory Collaboration
  • Adoption of New Approach Methodologies
  • Workflow Digitalization
  • Workflow Acceleration

Criticised

  • Manual Labor Dependence
  • Technology Displacement Threat
  • Regulatory Shift Risk
  • Regulatory Disruption Risk

What customers say

Workflow Acceleration
“With their integrated pharmacology and toxicology services, I accelerate study execution and advance therapeutic candidates more efficiently.”
High Data Quality
“The quality of preclinical safety data Charles River generates supports key development decisions and regulatory filings for our pipeline.”
Comprehensive Preclinical Capabilities
“I find Charles River's broad expertise in GLP and non-GLP in vivo studies, supported by advanced labs and extensive animal models, critical for R&D progress.”

Renewal intent

Plan to renew 38%
  • Will renew 11
  • Undecided 15
  • Not renewing 3

Plan to renew, by seniority

  • C-Suite 32% 22 answers
  • Director 40% 5 answers
  • Manager 100% 2 answers
  • 8.5/10 Average score from customers who will renew
  • 8.1/10 Average score from undecided customers
  • 6.3/10 Average score from customers not renewing

Top alternatives

Most weighed by Charles river customers

Report

For people who use Charles river

Do you use Charles river at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 38 customers of Charles river have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.